Abstract
The bioxalomycins, a novel complex of broad-spectrum antibiotics, were isolated from fermentations of Streptomyces viridodiastaticus subsp. "litoralis" LL-31F508. Bioxalomycin alpha 2, the major component of this complex, exhibited antibacterial activity. The MICs ranged from < or = 0.002 to 0.008 micrograms/ml for gram-positive organisms and from 0.50 to 4 micrograms/ml for gram-negative organisms. Bioxalomycin alpha 2 was found to be bactericidal and to inhibit bacterial DNA synthesis preferentially. Bioxalomycin alpha 2 protected mice from a lethal challenge with Staphylococcus aureus Smith. The 50% effective dose of bioxalomycin alpha 2 administered orally was 10 times greater than that when the drug was given subcutaneously or intravenously. These data suggest a stability or bioavailability problem when the compound is administered orally.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bull A. T., Goodfellow M., Slater J. H. Biodiversity as a source of innovation in biotechnology. Annu Rev Microbiol. 1992;46:219–252. doi: 10.1146/annurev.mi.46.100192.001251. [DOI] [PubMed] [Google Scholar]
- Greenstein M., Speth J. L., Maiese W. M. Mechanism of action of cinodine, a glycocinnamoylspermidine antibiotic. Antimicrob Agents Chemother. 1981 Oct;20(4):425–432. doi: 10.1128/aac.20.4.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hayashi T., Okutomi T., Suzuki S., Okazaki H. Inhibition of nucleic acid biosynthesis in procaryotic and eucaryotic cells by cyanocycline A. J Antibiot (Tokyo) 1983 Sep;36(9):1228–1235. doi: 10.7164/antibiotics.36.1228. [DOI] [PubMed] [Google Scholar]
- Hill G. C., Wunz T. P., MacKenzie N. E., Gooley P. R., Remers W. A. Computer simulation of the binding of naphthyridinomycin and cyanocycline A to DNA. J Med Chem. 1991 Jul;34(7):2079–2088. doi: 10.1021/jm00111a024. [DOI] [PubMed] [Google Scholar]
- Kluepfel D., Baker H. A., Piattoni G., Sehgal S. N., Sidorowicz A., Singh K., Vézina C. Naphthyridinomycin, a new broad-spectrum antibiotic. J Antibiot (Tokyo) 1975 Jul;28(7):497–502. doi: 10.7164/antibiotics.28.497. [DOI] [PubMed] [Google Scholar]
- Omura S. Thom Award Lecture. Trends in the search for bioactive microbial metabolites. J Ind Microbiol. 1992 Sep;10(3-4):135–156. doi: 10.1007/BF01569759. [DOI] [PubMed] [Google Scholar]
- Sampson B. A., Misra R., Benson S. A. Identification and characterization of a new gene of Escherichia coli K-12 involved in outer membrane permeability. Genetics. 1989 Jul;122(3):491–501. doi: 10.1093/genetics/122.3.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silver L. L., Bostian K. A. Discovery and development of new antibiotics: the problem of antibiotic resistance. Antimicrob Agents Chemother. 1993 Mar;37(3):377–383. doi: 10.1128/aac.37.3.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tomita F., Takahashi K., Shimizu K. DC-52, a novel antitumor antibiotic. 1. Taxonomy, fermentation and biological activity. J Antibiot (Tokyo) 1983 May;36(5):463–467. doi: 10.7164/antibiotics.36.463. [DOI] [PubMed] [Google Scholar]
- Walker G. C. Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli. Microbiol Rev. 1984 Mar;48(1):60–93. doi: 10.1128/mr.48.1.60-93.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zmijewski M. J., Jr, Miller-Hatch K., Mikolajczak M. The in vitro interaction of naphthyridinomycin with deoxyribonucleic acids. Chem Biol Interact. 1985 Jan;52(3):361–375. doi: 10.1016/0009-2797(85)90030-4. [DOI] [PubMed] [Google Scholar]